Key result
Bioprosthetic valve thrombosis can recur late and coexist with endocarditis despite successful fibrinolysis and anticoagulation.
Case Report (n=1)
Bioprosthetic valve thrombosis can occur years after implantation and may be successfully treated with thrombolysis, but can recur and coexist with endocarditis, highlighting the importance of multimodality echocardiography in diagnosis and management.
May prompt vigilance for late bioprosthetic thrombosis with endocarditis; leaves open optimal long-term strategies pending larger studies.
•Bioprosthetic valve thrombosis (BPVT) can occur beyond 3 months postimplantation.•BPVT can reoccur after successful treatment with fibrinolysis and anticoagulation.•Other forms of bioprosthetic valve dysfunction can coexist with thrombosis.•Echocardiography can promptly diagnose bioprosthesis thrombosis.•Management requires valve replacement, thrombolysis, or anticoagulation•After BPVT long-term anticoagulation may be required.
No takes yet. Share an insight, caveat, or question.
Apostolidou et al. (2019) conducted a case report in Bioprosthetic mitral valve thrombosis and endocarditis (n=1). Thrombolysis (tPA) and surgical valve replacement was evaluated. Bioprosthetic valve thrombosis can occur years after implantation, may coexist with endocarditis, and can recur despite successful initial treatment with fibrinolysis and anticoagulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: